Back to Screener

Rockwell Automation, Inc. Common Stock (ROK)

NYSE Large Cap

Healthcare › Measuring & Controlling Devices, NEC

$452.29
Market Cap: $50.3B
Data as of Mar 31, 2026 (TTM)

Price History

Feb 9, 2026 — May 24, 2026

Investment Snapshot

  • Trading 416% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 8/9 — financially strong with improving fundamentals
  • Strong ROE of 34.1% with 14.2% net margin

Rockwell Automation, Inc. Common Stock (ROK) is a Healthcare company operating in Measuring & Controlling Devices, NEC, listed on the NYSE , with a market capitalisation of $50.3 billion . Key value metrics: P/E ratio 41.9, P/B ratio 14.29, Piotroski F-Score 8 out of 9 (strong financial health) .

Value Score

Key Metrics

P/E Ratio
41.87
14.29
EPS
$10.80
Div. Yield
1.2%
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

Rockwell Automation, Inc. Common Stock — Fundamental Analysis Summary

Rockwell Automation, Inc. Common Stock (ROK) is currently trading 416% above its Graham Number of $87.71, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 41.9x.

On financial health, ROK shows a strong Piotroski F-Score of 8/9, indicating improving fundamentals across profitability, leverage, and efficiency, and strong return on equity of 34.1% (sector average: -20.6%), and elevated leverage with a debt-to-equity ratio of 1.05.

StockPik's composite Value Score for ROK is 55/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

ROK reports a solid gross margin of 45.1% (sector average: 40.1%) and a solid operating margin of 20.0%.

ROK shows revenue growing at 1% year-over-year, with earnings declining at 9%.

ROK pays a modest dividend yield of 1.2%.

Top Value Stocks in Healthcare

Symbol Price P/E Score
EMBC $3.90 2.1 100
HCM $13.31 5.1 100
GMAB $27.06 1.8 100
CGEN $2.71 7.3 100
INVA $22.89 5.8 100
High Piotroski F-Score stocks
Other stocks with F-Score ≥ 7 showing broad financial improvement
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
ROIV
Next
ROKU